Education
About Us
Working with TipRanks
Follow Us
Pharmarise Holdings Corp. (JP:2796)
:2796
RESEARCH TOOLSreports
Total Valuation
Pharmarise Holdings Corp. has a market cap or net worth of ¥5.69B. The enterprise value is ¥10.14B.
Market Cap¥5.69B
Enterprise Value¥10.14B
Share Statistics
Pharmarise Holdings Corp. has 12,060,381 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,060,381
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Pharmarise Holdings Corp.’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is -10.13%.
Return on Equity (ROE)-0.05
Return on Assets (ROA)-0.01
Return on Invested Capital (ROIC)-10.13%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee29.47M
Profits Per Employee-189.94K
Employee Count1,848
Asset Turnover1.85
Inventory Turnover17.40
Valuation Ratios
The current PE Ratio of Pharmarise Holdings Corp. is -19.34. Pharmarise Holdings Corp.’s PEG ratio is -0.66.
PE Ratio-19.34
PS Ratio0.00
PB Ratio0.83
Price to Fair Value0.92
Price to FCF2.90
Price to Operating Cash Flow2.28
PEG Ratio-0.66
Income Statement
In the last 12 months, Pharmarise Holdings Corp. had revenue of 54.47B and earned -351.00M in profits. Earnings per share was -33.35.
Revenue54.47B
Gross Profit8.45B
Operating Income916.00M
Pretax Income143.00M
Net Income-351.00M
EBITDA1.38B
Earnings Per Share (EPS)-33.35
Cash Flow
In the last 12 months, operating cash flow was 427.00M and capital expenditures -77.50M, giving a free cash flow of 349.50M billion.
Operating Cash Flow427.00M
Free Cash Flow349.50M
Free Cash Flow per Share28.98
Dividends & Yields
Pharmarise Holdings Corp. pays an annual dividend of ¥14, resulting in a dividend yield of 2.89%
Dividend Per Share¥14
Dividend Yield2.89%
Payout Ratio-23.06%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.33
52-Week Price Change-21.40%
50-Day Moving Average473.79
200-Day Moving Average526.87
Relative Strength Index (RSI)60.90
Average Volume (3m)14.80K
Important Dates
Pharmarise Holdings Corp. upcoming earnings date is Jul 16, 2025, TBA Not Confirmed.
Last Earnings DateDec 25, 2024
Next Earnings DateJul 16, 2025
Ex-Dividend DateMay 29, 2025
Financial Position
Pharmarise Holdings Corp. as a current ratio of 1.29, with Debt / Equity ratio of 132.80%
Current Ratio1.29
Quick Ratio1.04
Debt to Market Cap1.81
Net Debt to EBITDA4.06
Interest Coverage Ratio13.88
Taxes
In the past 12 months, Pharmarise Holdings Corp. has paid 485.00M in taxes.
Income Tax485.00M
Effective Tax Rate3.39
Enterprise Valuation
Pharmarise Holdings Corp. EV to EBITDA ratio is 8.98, with an EV/FCF ratio of 5.91.
EV to Sales0.23
EV to EBITDA8.98
EV to Free Cash Flow5.91
EV to Operating Cash Flow4.56
Balance Sheet
Pharmarise Holdings Corp. has ¥7.52B in cash and marketable securities with ¥13.78B in debt, giving a net cash position of ¥6.25B billion.
Cash & Marketable Securities¥7.52B
Total Debt¥13.78B
Net Cash¥6.25B
Net Cash Per Share¥518.39
Tangible Book Value Per Share¥97.02
Margins
Gross margin is 15.63%, with operating margin of 1.68%, and net profit margin of -0.64%.
Gross Margin15.63%
Operating Margin1.68%
Pretax Margin0.26%
Net Profit Margin-0.64%
EBITDA Margin2.53%
EBIT Margin0.38%
Analyst Forecast
The average price target for Pharmarise Holdings Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast11.85%
EPS Growth Forecast-315.15%